Sefelsa Approval Status
FDA Approved: No
Brand name: Sefelsa
Generic name: gabapentin
Dosage form: Extended Release Tablets
Previous Name: Serada
Company: Depomed, Inc.
Treatment for: Postmenopausal Symptoms
Sefelsa (gabapentin) is an investigational extended-release formulation of gabapentin in development for the treatment of menopausal hot flashes.
Development Status and FDA Approval Process for Sefelsa
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.